Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT02011685 · ClinicalTrials.gov registry record · NA

Practice-Based Trial of Home BP Telemonitoring Among Minority Stroke Survivors

A NA study, sponsored by NYU Langone Health.

Completed
Registry status
NA
Development phase
450
Enrollment target

NCT02011685: Completed NA study, sponsored by NYU Langone Health.

NCT02011685 is a NA study that has completed, run by NYU Langone Health. The registered enrollment target is 450 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (68% lower). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT02011685, a NA study, has completed, sponsored by NYU Langone Health.

COMPLETED
Registry status
NA
Development phase
450 participants
Enrollment target

Study Summary

This study will assess the comparative effectiveness, cost-effectiveness and sustainability of two telemonitoring interventions in reducing blood pressure and recurrent stroke among 450 high-risk Black and Hispanic stroke patients. The primary hypothesis is that home blood pressure telemonitoring supplemented with individualized, culturally tailored telephone-based nurse case management will have greater effects on blood pressure reduction and stroke recurrence and, while it will be more costly, it will also be more cost-effective than home blood pressure telemonitoring alone. Results of this study will provide strong empirical evidence to inform clinical guidelines and practice, which may lead to reductions in stroke disparities in the United States.

Interventions

  • BEHAVIORAL Home BP Telemonitoring (HBPTM)
  • BEHAVIORAL Nurse Case Management (NCM)

Trial Details

FieldValue
Enrollment Target 450 participants
Start Date 2014-04-18
Est. Completion 2019-12-31
Phase NA
NYU Langone Health

1,164 total trials

What the finished NCT02011685 record still lists

NCT02011685 is an interventional study that assigns participants to a tested intervention. The registered 450 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (68% lower).

The record links to 0 conditions, and to 2 interventions - of which Home BP Telemonitoring (HBPTM) is the first listed.

NCT02011685 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT02011685 about?

NCT02011685 is a clinical study titled "Practice-Based Trial of Home BP Telemonitoring Among Minority Stroke Survivors". This study will assess the comparative effectiveness, cost-effectiveness and sustainability of two telemonitoring interventions in reducing blood pressure and recurrent stroke among 450 high-risk Black and Hispanic stroke patients. The primary hypothesis is that home blood pressure telemonitoring su...

What is the current status of trial NCT02011685?

This trial is currently completed. It is a NA study. The enrollment target is 450 participants. The study started on 2014-04-18. Estimated completion is 2019-12-31.

What interventions are being tested in trial NCT02011685?

The interventions under investigation include: Home BP Telemonitoring (HBPTM) (BEHAVIORAL), Nurse Case Management (NCM) (BEHAVIORAL).

Who is sponsoring clinical trial NCT02011685?

This trial is sponsored by NYU Langone Health, which has 1,164 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT02011685's enrollment target sits among peer trials

450 225th of 2000 higher than 1,768 of 2,000 other NA trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT00515060 · 450 participants

    Psychophysical Studies of Cancer Therapy Pain

  • NCT01257269 · 450 participants

    Genotype and Phenotype Correlation in Hereditary Thrombotic Thrombocytopenic Purpura (Upshaw-Schulman Syndrome)

  • NCT03047161 · 450 participants

    Electrophysiology of Fetal Arrhythmia

  • NCT03269630 · 450 participants

    New Orleans Pulmonary Hypertension Biobank

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT02011685, the US trial registry maintained by the National Library of Medicine. NCT02011685 (mid enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.